The Acute Effects of Blueberries on Cognition and Mood in the Postpartum
BLUCAMP
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Blueberries are an excellent source of natural substances (flavonoids) with well-documented health benefits. Previous research has shown that consuming a serving of blueberries can improve mood in children, healthy young adults, and young adults with depressive symptoms. These results are consistent with a growing body of evidence from human and animal studies indicating that blueberries can have a beneficial effect on brain function and mental health. The postpartum period represents a challenging period whereby mood disorders such as postpartum depression become increasingly prevalent, in addition to this, mothers and fathers often report poorer cognition during this time. Therefore, it is of interest to explore whether acute blueberry supplementation can benefit mood and cognition for parents during this sensitive time. The aim of the present study is to examine whether consuming a drink containing powdered blueberries can improve mood and cognition in parents in the 0-6 month postpartum. The design follows a randomised, double blind, placebo controlled cross over design. Participants will be invited to take part in an in-person study investigating a fruit drink on mood and cognition. Participants will come to the Nutrition-cognition lab at the Psychology department at the University of Reading for a screening session, after providing informed consent, participants will return a week later to attend a 3-hr visit during which they will receive either a blueberry or placebo drink and complete computer tasks and standardised questionnaires. Participants will then return a week later and complete the same procedure, consuming the other intervention drink.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2024
CompletedFirst Posted
Study publicly available on registry
May 7, 2024
CompletedStudy Start
First participant enrolled
May 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedMay 7, 2024
May 1, 2024
1.3 years
May 2, 2024
May 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mean current affect
Assessed using scores from the Positive and Negative Affect Scale. This questionnaire has 20 items that describe some feelings and emotions. The participant needs to mark how much they are experiencing these feelings on a scale from 1-5. This produces scores of Positive Affect and Negative Affect; higher scores reflect higher positive or negative mood, respectively.
2 hours post ingestion
Secondary Outcomes (7)
Mean state anxiety
2 hours post ingestion
Mean subjective mood scores
2 hours post ingestion
Blood pressure
2 hours post ingestion
Mean subjective feelings
2 hours post ingestion
Verbal memory
2 hours post ingestion
- +2 more secondary outcomes
Other Outcomes (10)
General diet
Screening
Subjective sleep scores
Baseline
Mean postpartum-specific anxiety symptoms
Screening
- +7 more other outcomes
Study Arms (2)
Blueberry drink
EXPERIMENTAL46g freeze-dried wild blueberry (Vaccinium angustifolium) powder mixed with 250 ml water.
Placebo drink
PLACEBO COMPARATOR46g placebo powder matched for macronutrients, color, and flavor mixed with 250 ml water.
Interventions
Blueberry drink equivalent to 240g fresh blueberries.
Eligibility Criteria
You may qualify if:
- Participants must be a biological mother or father to an infant aged 0-6 months.
- Have a good understanding of English language
You may not qualify if:
- Allergic to blueberries or any other Vaccinium species
- Participation in other interventional studies within the last month
- Participants with cancer, or conditions affecting the liver, heart or kidneys due to unknown effects on flavonoid metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Daniel Lamport
Study Record Dates
First Submitted
May 2, 2024
First Posted
May 7, 2024
Study Start
May 20, 2024
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
May 7, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
Anonymized data may be made available on a platform such as Open Science Framework (www.osf.io) or a data repository linked to academic journals, in accordance with Open Science principles.